Sign In

Kathy Rowlen

CEO & Co-Founder, InDevR Inc.

Professional Background

Kathy Rowlen stands out as a significant figure in the life sciences and analytical technologies arena. Currently serving as the CEO and Chief Science Officer of InDevR Inc., she leads a team dedicated to innovating progressive analytical technologies specifically designed for biotherapeutics. Under her watchful eye, InDevR has accumulated a wealth of expertise that translates cutting-edge science into practical tools aimed at enhancing global health outcomes. Her dual role as both CEO and Chief Science Officer allows her to bridge the gap between scientific research and business operations, ensuring that the company's offerings are not only backed by robust scientific principles but are also tailored to meet the ever-evolving needs of healthcare practitioners around the world.

Education and Achievements

Kathy's academic journey laid the foundation for her illustrious career. She began with a Bachelor of Science in Chemistry from Grand Valley State University. This undergraduate experience ignited her passion for scientific inquiry and equipped her with the fundamental skills necessary for her future endeavors. Kathy pursued her Ph.D. in Chemistry at the University of Colorado Boulder, where she engaged in research that contributed significantly to her understanding of complex scientific problems. This rigorous training is evident in her approach to problem-solving and innovation in her current role.

After completing her Ph.D., Kathy embraced the role of a Professor of Chemistry at the University of Colorado Boulder, an esteemed position that allowed her to educate and inspire the next generation of scientists. Her tenure as a professor not only showcased her deep expertise in chemistry but also her commitment to academic excellence and student mentorship. Over the years, Kathy has published numerous papers and presented at various conferences, sharing her insights and discoveries in the field that have garnered attention both locally and internationally.

Achievements

Kathy Rowlen's influence extends beyond academia and into the impactful work she accomplishes at InDevR Inc. As a leader, she has been instrumental in positioning the company as a prominent player in the life sciences sector. Her extensive expertise in biotherapeutics and analytical technologies has propelled the organization to new heights, solidifying its reputation as a trusted partner in improving global health. Kathy’s ability to effectively communicate complex scientific concepts makes her an invaluable asset not only to InDevR but also to the broader scientific and entrepreneurial community. Her achievements reflect her relentless pursuit of knowledge, innovation, and dedication to advancing science for the betterment of society.

Highlights

Mar 8 · linkedin

Here at InDevR we "walk the walk" for women. Meg Gerold, a Lab Associate in our Expert Services department wrote: "I have been a Laboratory Associate in the Expert Services department for about 2 ½ years, helping to develop customized assays for our customers. When I first started, I was honestly surprised that there were so many women in important scientific and upper-management roles at InDevR, since that is usually not the norm at any given company. All these amazing women have cultivated an atmosphere where even someone like me, who is still in the beginning of my career, feels as though my work and input is genuinely valued and that I have opportunities to learn new things and grow in my role. I think it is important for young women to be able to see that they can truly make a difference and achieve whatever success they work toward, and I feel lucky and proud to work with so many women who embody that."

Happy International Women's Day!

Feb 29 · linkedin

Investing in our Customer’s Success   We have been quietly serving the influenza vaccine community for ten years. I think it is time to brag a bit. Maybe even loudly…   As far as I am aware, InDevR is the only life science tools company in the world that ensures that our CQA/QC test kits are responsive and appropriate for seasonal influenza vaccines. That has been true every year since 2013. It was true even when 3 strains changed in a single year (2018/2019)! We have achieved this remarkable feat by continuously sourcing and testing vast numbers of influenza antibodies from a large number of sources located in the US and around the world. Our library includes antibodies obtained from frontline influenza researchers at the FDA, CDC, Icahn School of Medicine at Mount Sinai, as well as other academic institutions and a range of commercial sources. The result is a unique and unprecedented library of curated influenza antibodies and an incredible network of partners. In addition, we have invested in the creation of new influenza antibodies in anticipation of future changes. We make these investments at risk. We make these investments to help our customers address the crucial issue of response time for influenza vaccines by doing the hard work in advance. We invest to be prepared.    If you work in, or are concerned about, influenza vaccines, you should seriously consider talking with us. We can help. We ARE prepared.

Related Questions

How did Kathy Rowlen's education at Grand Valley State University influence her scientific career?
In what ways has Kathy Rowlen's leadership as CEO of InDevR Inc. impacted the life sciences industry?
What motivated Kathy Rowlen to transition from a professor at the University of Colorado Boulder to a leadership role at InDevR Inc.?
How does Kathy Rowlen integrate her academic knowledge into her role as Chief Science Officer?
What innovations has Kathy Rowlen introduced in her work at InDevR Inc. that have improved global health outcomes?
Kathy Rowlen
Add to my network

Location

Boulder, Colorado, United States